Legal & General Group
OCEA

Legal & General Group’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Legal & General Group’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-829
Closed -$3.14K – 3529
2024
Q1 		$3.14K Hold
829
– – ﹤0.01% 3328
2023
Q4 		$553 Hold
829
– – ﹤0.01% 3375
2023
Q3 		$3.24K Hold
829
– – ﹤0.01% 3386
2023
Q2 		$4.98K Buy
+829
New +$4.86K ﹤0.01% 3375

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Legal & General Group's OCEA Position: Q2 2024 in Review

Legal & General Group sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2024, closing a stake of 829 shares — an estimated $3.14K sold.

Legal & General Group first reported a position in OCEA in Q2 2023 and held it in 4 quarters. The position peaked at $4.98K in Q2 2023. 36 funds tracked by Wall St. Rank hold OCEA as of Q2 2024.

  • Legal & General Group reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 829 Ocean Biomedical, Inc. Common Stock shares in Q2 2024, an estimated $3.14K.
  • Legal & General Group first reported a position in Ocean Biomedical, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
  • Legal & General Group's Ocean Biomedical, Inc. Common Stock position peaked at $4.98K in Q2 2023.
  • 36 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.